A New Genetic Fibrinogen Variant (Fibrinogen Erfurt I) Structurally Characterized by an Abnormal Bβ-Chain and Present both in Plasma and Platelets

Summary

An abnormal fibrinogen was discovered in the plasma of a clinically asymptomatic woman. This fibrinogen variant was analyzed by high resolution two–dimensional gel electrophoresis and its molecular abnormality established consisting in a slight decrease in molecular mass of the Bβ–chains. Analysis of fibrin revealed that cleavage of fibrinopeptide B by thrombin is normal, the molecular defect being confined to the β–portion of the Bβ–chain. The same fibrinogen variant was detected in the blood platelets of the proposita. This finding supports the assumption of a common origin of plasma and platelet fibrinogen pools. Family studies revealed the presence of the abnormal fibrinogen in a brother of the proposita, thus confirming the genetic nature of the observed variant. The underlying mutant gene occurs in both carriers in heterozygous state.

Keywords

Fibrinogen - Fibrinogen variant - Dysfibrinogenemia

• References

• 1 Rupp C, Beck EA. Congenital dysfibrinogenemia. In: Variants of Human Fibrinogen Beck EA, Furlan M. (Eds.) pp 65-130 Verlag Huber Bern 1984;
• 2 Bithell TC. Hereditary dysfibrinogenemia - the first 25 years. Acta Haematol 1984; 71: 145-149
• 3 Blombäck M, Blombäck B, Mammen EF, Prasad AS. Fibrinogen Detroit - a molecular defect in the N-terminal disulphide knot of human fibrinogen. Nature 1968; 218: 134-137
• 4 Henschen A, Kehl M, Southan C, Lottspeich F, Georgopoulos D. Genetically abnormal fibrinogens - some current characterisation strategies. In: Fibrinogen - Structure, Functional Aspects, Metabolism. Vol.2 Haverkate F, Henschen A, Nieuwenhuizen W, Straub PW. (Eds.) Walter de Gruyter; Berlin, New York: 1983. pp 125-144
• 5 Budzynski AZ, Marder VJ, Menache D. Guillin M-C. Defect in the gamma polypeptide chain of a congenital abnormal fibrinogen (Paris I). Nature 1974; 252: 66-67
• 6 Haverkate F, Timan G, Soria J, Soria C, Samama M. Studies on the structure of the fragment D moiety of abnormal fibrinogens: Influence of calcium ions. Thromb Res 1978; 13: 689-692
• 7 Brosstad F, Teige B, Olaisen B, Gravem K, Godal HC, Stormorken H. Two-dimensional electrophoresis characterization (ISO-DALT) of fibrinogen and fibrin subunit chains from four different genetic dysfibrinogen variants. In: Fibrinogen: Structure, Functional Aspects, Metabolism. Vol.2 Haverkate F, Henschen A, Nieuwenhuizen W, Straub PW. (Eds.) Walter de Gruyter; Berlin, New York: 1983. pp 145-153
• 8 Polack B, Valiron O, Concord E, Freyssinet JM, Hudry-Clergeon G. Molecular characterization of an abnormal fibrinogen by two-dimensional electrophoresis. Clin Chem 1984; 30: 2093-2097
• 9 Bang NU, Beller FK, Deutsch E, Mammen EF. Thrombosis and Bleeding Disorders. Georg Thieme Verlag. Stuttgart/Academic Press; New York, London: 1971
• 10 Lechner K. Blutgerinnungsstorungen. Springer Verlag; Berlin, Heidelberg, New York: 1982
• 11 Schulz RH. Eine einfache Bewertungsmethode von Leberparenchym-schäden (volumetrische Fibrinbestimmung). Acta Hepatol 1955; 3: 306-310
• 12 Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957; 17: 237-246
• 13 Masri MA, Masri SA, Boyd ND. Isolation of human fibrinogen of high purity and in high yield using polyethylene glycol 1000. Thromb Haemost 1983; 49: 116-119
• 14 Hagen I, Bjerrum OJ, Solum NO. Characterization of human platelet proteins solubilized with Triton X-100 and examined by crossed immunoelectrophoresis. Eur J Biochem 1979; 99: 9-22
• 15 Laemmli UK. Cleavage of structural proteins during the assembly-of the head of bacteriophage T4. Nature 1970; 227: 680-685
• 16 O’Farrell PH. High resolution two-dimensional electrophoresis of proteins. J Biol Chem 1975; 250: 4007-4021
• 17 Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of proteins utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254
• 18 Liu CY, Koehn JA, Morgan FJ. Characterization of fibrinogen New York 1. A dysfunctional fibrinogen with a deletion of Bβ (9-72) corresponding exactly to exon 2 of the gene J Biol Chem 1985; 260: 4390-4396
• 19 Francis CW, Nachman RL, Marder VJ. Plasma and platelet fibrinogen differ in γ chain content. Thromb Haemostas 1984; 51: 84-88
• 20 Chung DW, Davie EW. γ and γ’ chains of human fibrinogen are produced by alternative mRNA processing. Biochemistry 1984; 23: 4232-4236
• 21 Teige B, Gogstad G, Brosstad F, Olaisen B. Common structural genes for platelet and plasma fibrinogen. Blood 1985; 65: 120-126
• 22 Southan C, Lane DA, Knight I, Ireland H, Bottomley J. Fibrinogen Manchester. Detection of a heterozygous phenotype in the intraplatelet pool. Biochem J 1985; 229: 723-730
• 23 Soria J, Soria C, Samama M, Poirot E, Kling C. Human platelet fibrinogen: A protein different from plasma fibrinogen. Pathol Biol (suppl) 1976; 24: 15-17
• 24 Jandrot-Perrus M, Mosesson MW. Denninger M-H, Ménaché D. Studies of platelet fibrinogen from a subject with a congenital plasma fibrinogen abnormality (fibrinogen Paris I). Blood 1979; 54: 1109-1116
• 25 Kunicki TJ, Mosesson MW, Pidard D. Cleavage of fibrinogen by human platelet calcium-activated protease. Thromb Res 1984; 35: 169-184
• 26 Mosesson MW, Homandberg GA, Amrani DL. Human platelet fibrinogen gamma chain structure. Blood 1984; 63: 990-995